Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
Axim Biotechnologies Stock Quote

Axim Biotechnologies (OTC: AXIM)

Price as of May 23, 2024, 3:50 p.m. ET

Axim Biotechnologies Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
AXIM -51.54% -98.98% -60.02% -82%
S&P +28.01% +86.40% +13.26% +218%

Axim Biotechnologies Company Info

AXIM Biotechnologies, Inc. operates as a biotechnology company, which engages in the development of diagnostic healthcare solutions. Its product categories include Eye Health, SARS-CoV-2, and fentanyl neutralizing antibody test. The company was founded on November 18, 2010 and is headquartered in San Diego, CA.

News & Analysis


Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.